Sol-Gel Technologies (SLGL) EPS (Basic) (2017 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly EPS (Basic) of $1.31 for Q1 2026, down 58.45% year-over-year from $3.16 in Q1 2025, and up 105.91% quarter-over-quarter from -$22.22 in Q4 2025.
Sol-Gel Technologies (SLGL) EPS (Basic) (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported EPS (Basic) for 10 consecutive years, with $1.31 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 58.45% year-over-year to $1.31; the TTM figure through Mar 2026 stood at -$22.73 (down 32.15% YoY), while the FY2025 annual figure was -$23.71, down 6.85% from the prior year.
- EPS (Basic) improved to $1.31 in Q1 2026 per SLGL's latest filing, from -$22.22 in the prior quarter.
- Across five years, EPS (Basic) topped out at $4.3 in Q1 2023 and bottomed at -$22.22 in Q4 2025.
- Historically, EPS (Basic) has averaged -$3.12 across 5 years, with a median of $0.0 in 2022.
- On a YoY basis, EPS (Basic) climbed as much as 1739.55% in 2023 and fell as far as 18210899290.85% in 2023.
- Sol-Gel Technologies' EPS (Basic) stood at -$0.0 in 2022, then plunged by 18210899290.85% to -$19.68 in 2023, then dropped by 1.92% to -$20.06 in 2024, then retreated by 10.78% to -$22.22 in 2025, then soared by 105.91% to $1.31 in 2026.
- Business Quant data shows SLGL's EPS (Basic) at $1.31 in Q1 2026, -$22.22 in Q4 2025, and -$2.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | 1.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 |
| Dec 31, 2025 | -22.22 |
| Sep 30, 2025 | -2.26 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 3.16 |
| Dec 31, 2024 | -20.06 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 2.28 |
| Dec 31, 2023 | -19.68 |
| Sep 30, 2023 | -2.05 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 4.30 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 2.42 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |